Organic compounds -- part of the class 532-570 series – Organic compounds – Phosphorus esters
Reexamination Certificate
2005-07-05
2005-07-05
Wilson, James O. (Department: 1642)
Organic compounds -- part of the class 532-570 series
Organic compounds
Phosphorus esters
C536S023100, C536S024300, C536S024500, C536S026700, C536S026800
Reexamination Certificate
active
06914148
ABSTRACT:
The present invention provides oligomers which are specifically hybridizable with a selected sequence of RNA or DNA wherein at least one of the nucleoside moieties of the oligomer is modified to include a guanidinium group. These oligomers are useful for diagnostic, therapeutic and investigative purposes.
REFERENCES:
patent: 2933502 (1960-04-01), Klopping
patent: 3687808 (1972-08-01), Merigan et al.
patent: 3812173 (1974-05-01), Giraudon
patent: 3896160 (1975-07-01), Gaetzi
patent: 3929821 (1975-12-01), Beard et al.
patent: 3929823 (1975-12-01), Beard et al.
patent: 3929824 (1975-12-01), Beard et al.
patent: 3950395 (1976-04-01), Kolling et al.
patent: 3965113 (1976-06-01), Beard et al.
patent: 3993682 (1976-11-01), Kolling et al.
patent: 4024176 (1977-05-01), Kolling et al.
patent: 4032655 (1977-06-01), Kolling et al.
patent: 4415732 (1983-11-01), Caruthers et al.
patent: 4458066 (1984-07-01), Caruthers et al.
patent: 4469863 (1984-09-01), Ts'o et al.
patent: 4476301 (1984-10-01), Imbach et al.
patent: 4500707 (1985-02-01), Caruthers et al.
patent: 4668777 (1987-05-01), Caruthers et al.
patent: 4725677 (1988-02-01), Köster et al.
patent: 4794174 (1988-12-01), Secrist, III
patent: 4973679 (1990-11-01), Caruthers et al.
patent: 4977189 (1990-12-01), Tomcufcik et al.
patent: 5023243 (1991-06-01), Tullis
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5132418 (1992-07-01), Caruthers et al.
patent: RE34069 (1992-09-01), Köster et al.
patent: 5166315 (1992-11-01), Summerton et al.
patent: 5177196 (1993-01-01), Meyer, Jr. et al.
patent: 5185444 (1993-02-01), Summerton et al.
patent: 5188897 (1993-02-01), Suhadolnik et al.
patent: 5210264 (1993-05-01), Yau
patent: 5214134 (1993-05-01), Weis et al.
patent: 5216141 (1993-06-01), Benner
patent: 5235033 (1993-08-01), Summerton et al.
patent: 5264423 (1993-11-01), Cohen et al.
patent: 5264562 (1993-11-01), Matteucci
patent: 5264564 (1993-11-01), Matteucci
patent: 5276019 (1994-01-01), Cohen et al.
patent: 5278302 (1994-01-01), Caruthers et al.
patent: 5286717 (1994-02-01), Cohen et al.
patent: 5321131 (1994-06-01), Agrawal et al.
patent: 5399676 (1995-03-01), Froehler
patent: 5405938 (1995-04-01), Summerton et al.
patent: 5405939 (1995-04-01), Suhadolnik et al.
patent: 5434257 (1995-07-01), Matteucci et al.
patent: 5453496 (1995-09-01), Caruthers et al.
patent: 5455233 (1995-10-01), Spielvogel et al.
patent: 5466677 (1995-11-01), Baxter et al.
patent: 5470967 (1995-11-01), Huie et al.
patent: 5476925 (1995-12-01), Letsinger et al.
patent: 5489677 (1996-02-01), Sanghvi et al.
patent: 5519126 (1996-05-01), Hecht
patent: 5536821 (1996-07-01), Agrawal et al.
patent: 5539082 (1996-07-01), Nielsen et al.
patent: 5541306 (1996-07-01), Agrawal et al.
patent: 5541307 (1996-07-01), Cook et al.
patent: 5550111 (1996-08-01), Suhadolnik et al.
patent: 5561225 (1996-10-01), Maddry et al.
patent: 5563253 (1996-10-01), Agrawal et al.
patent: 5571799 (1996-11-01), Tkachuk et al.
patent: 5587361 (1996-12-01), Cook et al.
patent: 5596086 (1997-01-01), Matteucci et al.
patent: 5602240 (1997-02-01), De Mesmaeker et al.
patent: 5608046 (1997-03-01), Cook et al.
patent: 5610289 (1997-03-01), Cook et al.
patent: 5618704 (1997-04-01), Sanghvi et al.
patent: 5623070 (1997-04-01), Cook et al.
patent: 5625050 (1997-04-01), Beaton et al.
patent: 5633360 (1997-05-01), Bischofberger et al.
patent: 5663312 (1997-09-01), Chaturvedula
patent: 5670633 (1997-09-01), Cook et al.
patent: 5677437 (1997-10-01), Teng et al.
patent: 5677439 (1997-10-01), Weis et al.
patent: 5714331 (1998-02-01), Buchardt et al.
patent: 5719262 (1998-02-01), Buchardt et al.
patent: 5760202 (1998-06-01), Cook et al.
patent: 6166197 (2000-12-01), Cook et al.
patent: 6271358 (2001-08-01), Manoharan et al.
patent: 6534639 (2003-03-01), Manoharan et al.
patent: 612 925 (1979-08-01), None
patent: 615 157 (1980-01-01), None
patent: 2 117 293 (1971-10-01), None
patent: 2 147 103 (1972-03-01), None
patent: 2 109 454 (1972-09-01), None
patent: 2 250 911 (1974-04-01), None
patent: 33 28 502 (1985-02-01), None
patent: 0 071 926 (1983-02-01), None
patent: 0 850 950 (1998-07-01), None
patent: 2.086.795 (1971-12-01), None
patent: 48-80560 (1972-10-01), None
patent: 10-81686 (1998-03-01), None
patent: WO 99/14226 (1999-03-01), None
R. W. Hoffman, “Reactions of Electron-Rich Olefins,”Angewandte Chemie, International Edition, 7(10), 754-765 (Oct., 1968).
N. Wiberg, “Tetraaminoethylenes as Strong Electron Donors,”Angewandte Chemie, International Edition, 7(10), 766-778 (Oct., 1968).
Leyh et al., “Structures of Manganese(II) Complexes with ATP, ADP, and Phosphocreatine in the Reactive Central Complexes with Creatine Kinase: Electron Paramagnetic Resonance Studies with Oxygen-17-Labeled Ligands,”Biochemistry, 24(2), 308-316 (Jan. 15, 1985).
Ramasamy et al., “Nucleoside Peptides—IX. Synthesis of Peptide Derivatives of Sangivamycic Acid and Deaminosangivamycic Acid,”Tetrahedron, 44(4), 1023-1034 (1988).
Harusawa et al., “Efficient and β-Stereoselective Synthesis of 4(5)-methyl-5(4)-(5-amino-5-deoxy-β-D-ribofuranosyl)imidazole and Related Compounds Exhibiting Antiulcer Activity,”Chemical&Pharmaceutical Bulletin, 45(1), 53-61 (Jan., 1997);Chemical Abstracts, 126(15), p. 596, Abstr. No. 199776f (Apr. 14, 1997).
Barawkar et al. (I), “Deoxynucleic Guanidines/PNA (DNG/PNA) Chimeras Oligonucleoside Analogue Containing Cationic Guanidinium and Neutral Amide Linkages,”J. American Chemical Society, 121(44), 10418-10419 (Nov. 10, 1999).
Barawkar et al. (II), “Synthesis, Biophysical Properties, and Nuclease Resistance Properties of Mixed Backbone Oligodeoxynucleotides Containing Cationic Internucleoside Guanidinium Linkages: Deoxynucleic Guanidine/DNA Chimeras,”Proc. National Academy of Sciences USA, 95(19), 11047-11052 (Sep., 1998).
Barawkar et al. (III), “Synthesis of Protected Guanidinium Linked Dinucleoside for Incorporable into an Oligonucleotide Using a Solid Phase DNA Methodology,”Bioorganic&Medicinal Chemistry Letters, 8(12), 1517-1520 (1998).
Doronina et al., Synthesis of 5-Guanidinopyrimidine Nucleosides for Triple Helix-Mediated Guanine and Cytosine Recognition,Tetrahedron Letters, 39(7), 547-550 (Feb. 12, 1998).
Pannecouque et al. (I), “Synthesis, Enzymatic Stability and Physicochemical Properties of Oligonucleotides Containing an N-Cyanoguanidine Linkage,”Tetrahedron, 50(24), 7231-7246 (Jun. 13, 1994).
Pannecouque et al. (II), “Mixed Oligonucleotide Analogs with an Acyclic Carbohydrate Moiety and N-Cyanoguanidine Functionality,”Bioorganic&Medicinal Chemistry Letters, 4(10), 1203-1206 (May 19, 1994).
Vandendriessche et al., “Synthesis, Enzymatic Stability and Base Pairing Properties of Oligothymidylates Containing Thymidine Dimers with Different N-Substituted Guanidine Linkages,”J. Chemical Society, Perkin Transactions 1: Organic and Bio-organic Chemistry, 1993, (Issue No. 14), 1567-1575 (Jul. 21, 1993).
Pannecouque et al. (III), “Dimeric Building Blocks with N-Cyanoguanidine Linkage for Oligonucleotide Synthesis,”Tetrahedron Letters, 33(49), 7609-7612 (Dec. 1, 1992).
Agrawal et al. (eds.), “Methods of Molecular Biology”, inProtocols for Oligonucleotide Conjugates, Agrawal, S. (ed.), Humana Press, New Jersey, 1994,vol. 26, 1-72.
Altmann, K. et al., “Second Generation of Antisense Oligonucleotides: From Nuclease Resistance to Biological Efficacy in Animals,”Chimia, 1996,50, 168-176 (Apr., 1996.
Altmann, K. et al., “Second Generation Antisense Oligonucleotides-Inhibition of Pkc-1 and c-RAF Kinase Expression by Chimeric Oligonucleotides Incorporating 6-Substituted Carbocyclic Nucleosides and 2′-O-Ethylene Glycol Substituted Ribonucleosides,”Nucleosides&Nucleotides, 1997,16(7-9), 917-926.
Altmann, K. et al., “Second-Generation Antisense Oligonucleotides: Structure-Activity Relationships and the Design of Improved Signal-Transduction Inhibitors
Cook Phillip Dan
Manoharan Muthiah
Mohan Venkatraman
Prakash Thazha P.
Crane L. E.
ISIS Pharmaceuticals Inc.
Woodcock & Washburn LLP
LandOfFree
Guanidinium functionalized intermediates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Guanidinium functionalized intermediates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guanidinium functionalized intermediates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3394733